Lonza launches Capsugel Colorista

The capsules offer a broad selection of colourants, allowing pharmaceutical manufacturers access to a vast array of colours

Capsule Delivery Solutions, part of Lonza Pharma & Biotech, is launching the Capsugel Colorista product, a high-quality capsule based on an all-colourants formulation. This new capsule further expands the Lonza Capsugel R&D offering.

Colorista capsules contain a broad selection of colourants suitable for use in major markets, allowing pharmaceutical customers to have access to a wide array of colours, and are available in both Vcaps Plus (HPMC) and Coni-Snap gelatin.

“A common issue faced by drug product developers is that the color composition choice for the commercial drug product is often made after initial stability studies. If new colors are introduced, it may require additional studies, which can result in costly delays," said Emmanuelle Saugues, Color Lab EMEA Supervisor for Lonza.

"To address this problem, we have developed Colorista capsules at the Capsugel Color Lab.”

Colorista capsules offer more than 150 colour options in Coni-Snap gelatin capsules and more than 50 colour options in Vcaps Plus capsules and are available in different sizes to enable the encapsulation of a wide range of doses and formulations.

Niki Kolokotronis, Sales Director Americas for Capsule Delivery Solutions, explained: “Colorista capsules meet the demand of our pharmaceutical customers who look for solutions that cut down on development time while giving them flexibility to progress with technical development before the final commercial color decision is taken.”

Like all other products in the Capsugel portfolio, Colorista capsules rely on Color Lab services, as well as regulatory and compliance support, to help Lonza’s customers in the formulation, design and manufacturing of high-quality oral delivery solutions.

The addition of Colorista capsules broaden the already comprehensive preclinical and clinical portfolio of Capsugel empty capsules, providing solutions for the full drug product development process.